Skip to main content

Displaying 2701 - 2712 of 4555

All Star Charts Premium

Buying Weakness in Market Leaders

December 31, 2021

From the desk of Steve Strazza @Sstrazza

Yesterday, we wrote a post about scanning for new lows, putting our own spin on a strategy called "Wall Street's only free lunch."

I was joking with JC that it felt a bit uncomfortable to search through such a weak list of stocks. After all, we’re used to scanning for strength.

But the scan was a fun exercise, and we found some weakness we want to be buying in secular leaders. 

The universe wasn’t exactly full of strong stocks, as we were scanning for new 52-week lows. But that’s OK; we have plenty others for that.

In this post, we’re going to walk through another scan we did internally this week. Unlike the "free lunch," this one is more in line with our top-down approach of finding the strongest stocks in the strongest groups.

While we're still scanning for new lows, we’re doing so on a much shorter time frame, and we're adding additional filters to ensure all the stocks on our list are leaders.

BNN Bloomberg: Stocks, Bonds and Dutch Masters

December 31, 2021

The bond market continues to price in higher inflation and higher interest rates.

The types of stocks that tend to do well in that environment are Energy and Financials. So that's where we're looking.

An area that continues to see relative strength is in Semiconductors. One name in particular stands out from Amsterdam is ASML.

We talk about all of this and more in this short New Year's Eve Clip:

All Star Charts Premium

The Hall of Famers (12-31-2021)

December 31, 2021

From the desk of Steve Strazza @Sstrazza

Our Hall of Famers list is composed of the 100 largest US-based stocks.

These stocks range from the mega-cap growth behemoths like Apple and Microsoft – with market caps in excess of $2T – to some of the new-age large-cap disruptors such as Moderna, Square, and Snap.

It has all the big names and more.

It doesn’t include ADRs or any stock not domiciled in the US. But don’t worry; we developed a separate universe for that which you can check out here.

The Hall of Famers is simple.

We take our list of 100 names and then apply our technical filters so the strongest stocks with the most momentum rise to the top.

Let’s dive right in and check out what these big boys are up to.

Here’s this week’s list:

And here’s how we arrived at it:

[Video] It Is Different This Time

December 31, 2021

Our friends over at Stockcharts.com asked me to put together a short video on the most important theme of 2021.

For me, it's hard to ignore how breadth deterioration throughout the most the year impacted sentiment. This summer, the extreme levels of bullishness among individual investors and financial advisors became a headwind for stocks.

After the prices of those stocks deteriorated further into the Fall, that sentiment flipped to the opposite extreme. We came into December 2021 with the most bears in over a year and fewest bulls since April 2020.

As we enter 2022, sentiment is very different than how things looked entering 2020 and 2021.

By my work, this time is different. Very different.

The Outperformers

December 31, 2021

We debuted a new scan recently- The Outperformers.

The Outperformers is our newest scan that pinpoints the very best stocks in the market. It’s the fastest, easiest way to find quality names that are primed for major moves.

The goal is that as the market rally progresses, the sector rotation within the market will reflect in this scan. So while our Top/Down Analysis helps us with the broader view of the market, this Bottom/Up scan makes sure that we catch the slightest change in sentiment.

Hungry For A Free Lunch

December 30, 2021

From the desk of Steve Strazza @Sstrazza

"There's no such thing as a free lunch."

Many of you are already familiar with this popular market adage as it is a commonly used quip in our industry.

All it really means is that you can't get something for nothing from the market.

Have you ever bought a high-yielding stock for the dividend and rode it into a big drawdown just for them to announce they're cutting the payout?

Did you listen to a friend about a biotech stock that was supposed to rip higher on positive FDA results... but it actually gapped lower?

How about following the analyst community into a stock that was a consensus buy... until it turned out not to be?

In all of these scenarios, the investor is simply looking for a free lunch. And 9 times out of 10, these situations don't work out. There are no easy investments or get-rich-quick tricks on wall street. At least not sustainable ones. You have to put in the work.

One rule that I live by for my own investing is this: "If it seems too good to be true, it probably is."

All Star Charts Premium

The Short Report (12-29-2021)

December 29, 2021

From the desk of Steve Strazza @Sstrazza

When investing in the stock market, we always want to approach it as a market of stocks.

Regardless of the environment, there are always stocks showing leadership and trending higher.

We may have to look harder to identify them depending on current market conditions… but there are always stocks that are going up.

The same can be said for weak stocks. Regardless of the environment, there are always stocks that are going down, too. 

We already have multiple scans focusing on stocks making all-time highs, such as Hall of Famers, Minor Leaguers, and the 2 to 100 Club. We filter these universes for stocks that are exhibiting the best momentum and relative strength characteristics. 

The point is that we spend a lot of time identifying and writing about leading stocks every week, via multiple reports. Now, we’re also highlighting lagging stocks on a recurring basis.

Welcome to the Short Report.

Nifty Pharma Feeling Better?

December 29, 2021

We've been talking about how the major strength in the current market has been coming through in IT. But what we also noticed is that while Nifty Pharma wasn't looking pretty on an absolute basis, the relative strength is pointing in a different direction.

Pharma has been gaining our attention for the past few weeks. This post will see if broad participation is back in Pharma or just a few value weightage stocks are gaining higher.

Buy, Avoid, Sell, Or Hold? RBL Bank

December 28, 2021

Today we're introducing a new series of posts that we will include in our general analysis.

We're calling this the BASH Series. What does this mean and what do we do?

We look at stocks in the market that are experiencing extreme moves, and we share our views. So we will tell you what we'd do: Buy, Avoid, Sell, or Hold. And that's how we arrive at BASH (you have to make acronyms that make a word. Just sticks better, so bear with it. Haha!)

Today we're here to discuss RBL Bank Bank. So let's do just that.

All Star Charts Premium

Under the Hood (12-27-2021)

December 27, 2021

From the desk of Steve Strazza @Sstrazza.

Welcome back to our latest Under the Hood column, where we'll cover all the action for the week ended December 24, 2021. This report is published bi-weekly and rotated with our Minor Leaguers column.

What we do here is analyze the most popular stocks during the week and find opportunities to either join in and ride these momentum names higher, or fade the crowd and bet against them.

All Star Charts Premium

Follow The Flow (12-27-2021)

December 27, 2021

From the desk of Steve Strazza @sstrazza

This is one of our favorite bottom-up scans: Follow the Flow. In this note, we simply create a universe of stocks that experienced the most unusual options activity — either bullish or bearish… but NOT both.

We utilize options experts, both internally and through our partnership with The TradeXchange. Then, we dig through the level 2 details and do all the work upfront for our clients. Our goal is to isolate only those options market splashes that represent levered and high-conviction, directional bets.

We also weed out hedging activity and ensure there are no offsetting trades that either neutralize or cap the risk on these unusual options trades.

All Star Charts Premium

Wall Street Is Worried. Good!

December 27, 2021

Wall Street sell side analysts are coming out with their 2022 forecasts.

And we all know how accurate those tend to be ;)

In the latest float of the bear parade, wall street's sell side analysts are putting out some of the most bearish forecasts in recent memory.

From the WSJ,

And we already know that Individual investors (AAII) and Financial Advisors (II) are much more bearish going into 2022 than they were over the prior two years.